Dual-Energy Computed Tomography of the Knee, Ankle, and Foot: Noninvasive Diagnosis of Gout and Quantification of Monosodium Urate in Tendons and Ligaments

Abstract

Gout is a true crystal deposition arthropathy caused by the precipitation of monosodium urate into joints and periarticular soft tissues. It is the most common inflammatory arthropathy in men and women of older age with a male-to-female ratio of 3 to 8:1. The disease may progress from asymptomatic hyperuricemia through symptomatic acute gout attacks with asymptomatic periods into chronic symptomatic tophaceous gout. Although invasive arthrocentesis and demonstration of monosodium urate crystals on polarized light microscopy is definitive for the diagnosis of gout, dual-energy computed tomography (CT) allows for noninvasive visualization and reproducible volume quantification of monosodium urate crystals. Based on the high diagnostic performance, dual-energy CT has been included in the 2015 American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Classification Criteria for Gout. Increasing evidence indicates the usefulness of dual-energy CT to guide the management of patients with suspected gout and monitor the effectiveness of urate-lowering medical therapy.

Keywords

dual energy - computed tomography - gout - crystal - monosodium urate

• References

• 1 Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 2006; 8 (Suppl. 01) S1
• 2 Schlesinger N. Diagnosing and treating gout: a review to aid primary care physicians. Postgrad Med 2010; 122 (2) 157-161
• 3 Pittman JR, Bross MH. Diagnosis and management of gout. Am Fam Physician 1999; 59 (7) 1799-1806 , 1810
• 4 Fox IH, Kelley WN. Studies on the mechanism of fructose-induced hyperuricemia in man. Adv Exp Med Biol 1974; 41: 463-470
• 5 Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol 2007; 3 (8) 443-449
• 6 Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford) 2009; 48 (Suppl. 02) ii2-ii8
• 7 Lawrence RC, Felson DT, Helmick CG , et al; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58 (1) 26-35
• 8 Puig JG, de Miguel E, Castillo MC, Rocha AL, Martínez MA, Torres RJ. Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 2008; 27 (6) 592-595
• 9 Neogi T, Jansen TL, Dalbeth N , et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015; 74 (10) 1789-1798
• 10 Gentili A. Advanced imaging of gout. Semin Musculoskelet Radiol 2003; 7 (3) 165-174
• 11 Krauss B, Grant KL, Schmidt BT, Flohr TG. The importance of spectral separation: an assessment of dual-energy spectral separation for quantitative ability and dose efficiency. Invest Radiol 2015; 50 (2) 114-118
• 12 Omoumi P, Becce F, Racine D, Ott JG, Andreisek G, Verdun FR. Dual-energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (Part 1). Semin Musculoskelet Radiol 2015; 19 (5) 431-437
• 13 Johnson TR, Krauss B, Sedlmair M , et al. Material differentiation by dual energy CT: initial experience. Eur Radiol 2007; 17 (6) 1510-1517
• 14 Mallinson PI, Coupal T, Reisinger C , et al. Artifacts in dual-energy CT gout protocol: a review of 50 suspected cases with an artifact identification guide. AJR Am J Roentgenol 2014; 203 (1) W103–109
• 15 Fritz J, Fishman EK, Corl F, Carrino JA, Weber KL, Fayad LM. Imaging of limb salvage surgery. AJR Am J Roentgenol 2012; 198 (3) 647-660
• 16 Dalbeth N, Kalluru R, Aati O, Horne A, Doyle AJ, McQueen FM. Tendon involvement in the feet of patients with gout: a dual-energy CT study. Ann Rheum Dis 2013; 72 (9) 1545-1548
• 17 Choi HK, Burns LC, Shojania K , et al. Dual energy CT in gout: a prospective validation study. Ann Rheum Dis 2012; 71 (9) 1466-1471
• 18 Glazebrook KN, Guimarães LS, Murthy NS , et al. Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation. Radiology 2011; 261 (2) 516-524
• 19 Wu H, Xue J, Ye L, Zhou Q, Shi D, Xu R. The application of dual-energy computed tomography in the diagnosis of acute gouty arthritis. Clin Rheumatol 2014; 33 (7) 975-979
• 20 Metzger SC, Koehm M, Wichmann JL , et al. Dual-energy CT in patients with suspected gouty arthritis: effects on treatment regimen and clinical outcome. Acad Radiol 2016; 23 (3) 267-272
• 21 O'Connor PJ. Crystal deposition disease and psoriatic arthritis. Semin Musculoskelet Radiol 2013; 17 (1) 74-79
• 22 Schwenzer NF, Kötter I, Henes JC , et al. The role of dynamic contrast-enhanced MRI in the differential diagnosis of psoriatic and rheumatoid arthritis. AJR Am J Roentgenol 2010; 194 (3) 715-720
• 23 Fritz J, Galeczko EK, Schwenzer N , et al. Longitudinal changes in rheumatoid arthritis after rituximab administration assessed by quantitative and dynamic contrast-enhanced 3-T MR imaging: preliminary findings. Eur Radiol 2009; 19 (9) 2217-2224
• 24 Bencardino JT, Hassankhani A. Calcium pyrophosphate dihydrate crystal deposition disease. Semin Musculoskelet Radiol 2003; 7 (3) 175-185
• 25 Omoumi P, Verdun FR, Guggenberger R, Andreisek G, Becce F. Dual-energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (Part 2). Semin Musculoskelet Radiol 2015; 19 (5) 438-445